Products

Mantiscope
Mantiscope
Lab & Diagnostics
Mantiscope is an IVD system that digitizes biological slides and uses AI for automatic red and white blood cell classification, abnormality detection, and percentage calculation from smear images. It also includes a laboratory management system and tele-pathology features.

See all 1 product →

About Mantiscope

Mantiscope is a healthcare AI company that has developed an in-vitro diagnostic (IVD) system to automate and enhance blood cell analysis. The system comprises an automated scanner that digitizes biological slides and a cloud-based AI platform for examining smear samples. This technology aims to streamline diagnostics, improve accuracy, and accelerate blood cell analysis workflows for laboratories and healthcare providers.

The company’s primary focus is to address the disparity in diagnostic services, particularly in rural and underserved areas where access to expert hematologists and well-equipped laboratories may be limited. Mantiscope’s platform offers automated red and white blood cell classification (identifying up to 60 types of cell patterns), abnormality detection, and the ability to flag risky smear samples. The system also includes a tele-pathology feature, allowing physicians to remotely access and control the hardware for real-time diagnosis, and an annotation platform for physicians to edit AI recommendations, fostering an agile and updatable AI in the cloud. Mantiscope’s solution is designed to reduce the time physicians spend on non-risky patients and facilitate quicker diagnoses, which is crucial for conditions like leukemia.

Focus Areas

blood cell analysis artificial intelligence digital pathology hematology in-vitro diagnostics cloud computing IoT tele-pathology laboratory management systems

Business Intelligence

Key InvestorsG4A, Big Bang | Startup Challenge, S2 Xpeed
PartnershipsHacettepe University, Tobb Etu, Afyon, Hospital Clínic de Barcelona, Tuseb (for pilot tests)
TechnologyCloud-based AI system, automated scanner, IoT integration, annotation platform for physician feedback

What Physicians Need to Know

Specialization: Blood Disease Diagnostics
Mantiscope specializes in AI-powered blood smear analysis for the detection and classification of various blood diseases, including leukemia. They focus on red and white blood cell classification (up to 60 cell patterns), abnormality detection, and calculating percentages of WBC and RBC.
Target Audience: Underserved & Rural Areas
A key differentiator for Mantiscope is its focus on providing advanced diagnostic capabilities to rural and suburban areas, and places lacking expert hematologists. Their cloud-based system allows costly AI-based systems to be centralized while distributing affordable scanners to these areas.
Technology Stack: Cloud-based IVD System with AI & IoT
Mantiscope's core technology is an In-Vitro Diagnostics (IVD) system comprising a scanner and a cloud-based AI. The scanner digitizes biological slides and uploads images to the cloud, where AI examines smear samples. The system also incorporates IoT for connectivity and an annotation platform for physicians to refine AI recommendations, creating an agile and updatable AI.
Key Differentiator: Remote Collaboration & Accessibility
Mantiscope offers remote collaboration capabilities, allowing physicians to access and control the device and provide diagnoses from anywhere globally through a web-based platform. This addresses the challenge of limited access to specialists in remote locations.
Efficiency: Rapid Diagnosis & Reduced Workload
The system aims to significantly reduce diagnosis times, particularly for critical diseases like leukemia, from several days to the same day. It helps physicians by pre-classifying cells and highlighting risky samples, thereby saving time and streamlining the diagnostic workflow.
Physician Tip

For physicians, Mantiscope offers a powerful tool to enhance diagnostic accuracy and efficiency, especially in settings with limited access to hematology experts. The AI-driven pre-analysis of blood smears, including classification of up to 60 cell patterns and abnormality detection, can significantly reduce the manual workload and accelerate the diagnostic process for diseases like leukemia. The cloud-based nature and tele-pathology system enable remote consultation and collaboration, allowing for expert opinions on challenging cases regardless of geographical location. Furthermore, the annotation platform allows physicians to contribute to and refine the AI's learning, ensuring the system remains agile and continuously improves. This can lead to earlier interventions and improved patient outcomes, particularly in time-sensitive conditions.

Mantiscope's system is designed as an IVD system with a scanner and cloud-based AI. While specific third-party integrations are not explicitly detailed, the cloud-based platform and laboratory management system suggest potential for integration with existing hospital information systems (HIS) or electronic health records (EHR) for seamless patient data management and report sharing. The ability to share smear sample images via URL also facilitates easy collaboration with other experts.

Products by Mantiscope

1 product in the directory

Mantiscope
Mantiscope
Lab & Diagnostics
Mantiscope is an IVD system that digitizes biological slides and uses AI for automatic red and white blood cell classification, abnormality detection, and percentage calculation from smear images. It also includes a laboratory management system and tele-pathology features.

Reviews & Opinions

No web reviews on file yet for Mantiscope. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Mantiscope.

Loading videos...

Videos load interactively. If none appear, search YouTube for Mantiscope →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Mantiscope offers an IVD system that includes a scanner and a cloud-based AI for blood cell analysis, specifically for peripheral blood smears and bone marrow aspirations. This system digitizes biological slides, classifies red and white blood cells (identifying 60 types of cell patterns), detects abnormalities, and flags risky samples. For physicians, it provides an AI assistant for faster and more accurate diagnoses, and an annotation platform to edit AI recommendations, making the AI agile and updatable. For administrators, it offers a laboratory management system for online workflow, patient/physician/report management, and tele-pathology capabilities for remote diagnosis and expert collaboration, aiming to improve efficiency and access to diagnostics, especially in areas lacking specialists.
Mantiscope's system uploads images to the cloud by hashing the patient's barcode, indicating a focus on data anonymization or pseudonymization. While specific details on their HIPAA and GDPR compliance are not extensively detailed, healthcare AI systems generally must adhere to these regulations, which involve robust data privacy and security measures, transparent processes for AI decisions, and accountability structures. Mantiscope's cloud-based nature and focus on data management suggest these are critical considerations.
Mantiscope's website does not publicly list specific pricing for its IVD system. However, their approach of centralizing the costly AI in the cloud and distributing hardware scanners in rural areas suggests a model designed to be more cost-effective than high-cost automation for well-equipped hospitals. For detailed pricing, it would be necessary to contact Mantiscope directly for a demo or a quote.
Mantiscope provides an annotation platform that allows physicians to edit AI recommendations, which also contributes to an agile and updatable AI system. While specific details on dedicated customer support channels or formal training programs are not explicitly outlined, the company emphasizes collaboration and development of new decision support systems, suggesting a hands-on approach to user engagement and system refinement.
Mantiscope has engaged in collaborations with hematology professors and has been involved in pilot tests at hospitals in Turkey and at Hospital Clu00ednic de Barcelona. They have also received investment from organizations like G4A, Big Bang | Startup Challenge, and S2 Xpeed. Mantiscope encourages contact for collaboration and development of new decision support systems.
Mantiscope was founded in 2018 and is a privately held company headquartered in Ankara, Turkey, with an Asia-Pacific representative office in Tokyo, Japan. They have received a European Commission Seal of Excellence and a Tu00dcBu0130TAK 1507 Research and Development Grant. Mantiscope's vision is to make timely and accurate blood disease diagnoses accessible to all, especially in rural areas, by providing cost-effective, cloud-based AI solutions, aiming to prevent blood cancer deaths worldwide.
Mantiscope offers a laboratory management system that allows for online work, including inserting patients, physicians, and test reports, and sharing reports with other physicians. The system is designed to digitize biological samples and upload images to the cloud by hashing patient barcodes, suggesting an interface for data input. While direct integration with specific EHR systems isn't detailed, the platform's focus on managing laboratory workflows and sharing reports implies a capability to interact with broader healthcare IT ecosystems.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.